Overall and Comparative Risk of Shingles With Advanced Therapies in Patients With Inflammatory Bowel Diseases

Documenti analoghi

• Research Communication: Risk of Tuberculosis With Advanced Therapies in 20,705 Patients With Inflammatory Bowel Diseases in Low Incidence Regions—A U.S. Claims‐Based Study
  di: Dhruv Ahuja, et al.
  Pubblicazione: (2025)
• Editorial: Are Antidepressant Medications Safe in Inflammatory Bowel Disease? Authors' Reply
  di: Bharati Kochar, et al.
  Pubblicazione: (2025)
• Letter: Bowel Preparation Quality in Patients With Crohn's Disease—Authors' Reply
  di: Virginia Solitano, et al.
  Pubblicazione: (2024)
• Meta‐Analysis: Improvement of Bowel Urgency With Advanced Therapies for Inflammatory Bowel Disease
  di: Purab Patel, et al.
  Pubblicazione: (2025)
• Systematic Review: Ultrasound Goes Echo—Decarbonising Inflammatory Bowel Disease Care Through Intestinal Ultrasound
  di: Sara Massironi, et al.
  Pubblicazione: (2025)